SCHEMBL26214620

SCHEMBL26214620

Cc1ccc([Si](c2ccccc2)(c2ccccc2)c2cccc(-c3cc(-n4c5ccccc5c5ccccc54)nc(-n4c5ccccc5c5ccccc54)c3)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.34
LMNA P02545 4/20 0.34
MAPT P10636 3/20 0.34
HTT P42858 2/20 0.34
KDM4E B2RXH2 3/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
RXFP1 Q9HBX9 2/20 0.33
NR1I2 O75469 1/20 0.33
EGFR P00533 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
TBXA2R P21731 1/20 0.33
PTGS2 P35354 1/20 0.33
OPRD1 P41143 1/20 0.33
PDE4D Q08499 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
TP53 P04637 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26214586 0.93 RXFP1 (0.37) ALDH1A1MAPTKDM4ERXFP1NR1I2
SCHEMBL23622189 0.92 KDM4E (0.37) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL23622649 0.92 KDM4E (0.37) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL23623064 0.89 L3MBTL1 (0.42) ALDH1A1MAPTHTTKDM4ERXFP1
SCHEMBL23622545 0.86 L3MBTL1 (0.42) ALDH1A1MAPTHTTKDM4EGAA
SCHEMBL23622654 0.86 HTT (0.36) ALDH1A1LMNAMAPTHTTKDM4E
SCHEMBL25874644 0.86 KDM4E (0.39) ALDH1A1LMNAMAPTHTTKDM4E
SCHEMBL26214622 0.85 ALDH1A1 (0.34) ALDH1A1LMNAMAPTHTTKDM4E
SCHEMBL23622424 0.84 KDM4E (0.35) ALDH1A1KDM4EHPGDL3MBTL1ATM
SCHEMBL23622750 0.84 KDM4E (0.35) ALDH1A1KDM4EHPGDL3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-12 US disclosed
US-20230292539-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed
US-20230292593-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed
US-20230279029-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NR1H2, OXER1, NR1H3 ALDH1A1 669/4885LMNA 337/4885MAPT 4351/4885
US-20230279029-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, EHD1 ALDH1A1 1685/4885LMNA 1657/4885MAPT 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.